Cargando…
Commentary: Is it time to re-evaluate the empiric intravitreal antibiotic therapy in infectious bacterial endophthalmitis?
Autor principal: | Das, Taraprasad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332985/ https://www.ncbi.nlm.nih.gov/pubmed/35502055 http://dx.doi.org/10.4103/ijo.IJO_393_22 |
Ejemplares similares
-
Commentary: Usage of intravitreal steroids in endophthalmitis: Horns of a dilemma
por: Sen, Sagnik, et al.
Publicado: (2022) -
Commentary: Intravitreal moxifloxacin for acute postoperative endophthalmitis: Is it as safe and efficacious as the age-old recommended intravitreal vancomycin and ceftazidime?
por: Bhojwani, Deepak
Publicado: (2021) -
Enterobacter endophthalmitis: Treatment with intravitreal tazobactam- piperacillin
por: Singh, Trehan Hemant, et al.
Publicado: (2007) -
Endophthalmitis Management: Stain-Culture, Empirical Treatment, and Beyond
por: Das, Taraprasad
Publicado: (2020) -
Commentary: Peripartum endogenous bacterial endophthalmitis: A conundrum
por: Biswas, Jyotirmay, et al.
Publicado: (2020)